Authors: Dziadulewicz, EK Walpole, CS Snell, CR Wrigglesworth, R Hughes, GA Beattie, D Wood, JN Beech, MM Coote, PR

Citation: Ek. Dziadulewicz et al., Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffold, BIOORG MED, 11(5), 2001, pp. 705-709

Authors: Dziadulewicz, EK Ritchie, TJ Hallett, A Snell, CR Ko, SY Wrigglesworth, R Hughes, GA Dunstan, AR Bloomfield, GC Drake, GS Brown, MC Lee, W Burgess, GM Davis, C Yaqoob, M Perkins, MN Campbell, EA Davis, AJ Rang, HP

Citation: Ek. Dziadulewicz et al., 1-(2-nitrophenyl)thiosemicarbazides: A novel class of potent, orally active non-peptide antagonist for the bradykinin B-2 receptor, J MED CHEM, 43(5), 2000, pp. 769-771

Authors: Burnouf, C Auclair, E Avenel, N Bertin, B Bigot, C Calvet, A Chan, K Durand, C Fasquelle, V Feru, F Gilbertsen, R Jacobelli, H Kebsi, A Lallier, E Maignel, J Martin, B Milano, S Ouagued, M Pascal, Y Pruniaux, MP Puaud, J Rocher, MN Terrasse, C Wrigglesworth, R Doherty, AM

Citation: C. Burnouf et al., Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indoles:Discovery of potent, selective phosphodiesterase type 4 inhibitors, J MED CHEM, 43(25), 2000, pp. 4850-4867

Authors: Burgess, GM Perkins, MN Rang, HP Campbell, EA Brown, MC McIntyre, P Urban, L Dziadulewicz, EK Ritchie, TJ Hallett, A Snell, CR Wrigglesworth, R Lee, W Davis, C Phagoo, SB Davis, AJ Phillips, E Drake, GS Hughes, GA Dunstan, A Bloomfield, GC

Citation: Gm. Burgess et al., Bradyzide, a potent non-peptide B-2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia, BR J PHARM, 129(1), 2000, pp. 77-86